Abridge
Gives clinicians a draft to review after an encounter instead of starting the note from scratch.
Abridge Funding History
Abridge develops AI software that turns conversations between clinicians and patients into structured medical documentation. It serves health systems, focusing on clinical notes and the documentation workflow surrounding patient visits.
Company Overview
Abridge Funding Timeline
Abridge’s financing announcements trace its move from clinical documentation into coding and reimbursement workflows.
Series E
$300M · $5.3B valuation
Abridge announced the round as it expanded its documentation tools to capture billing codes and supporting evidence during visits, reducing the need to follow up with clinicians later.
Led by Andreessen Horowitz. Participation included Khosla Ventures.
Source · abridge.com ↗Series D
US$250 million
The round accompanied a new reasoning engine designed to bring patient history, documentation preferences, and billing requirements into notes generated during care.
Led by Elad Gil, IVP. Participation included Bessemer, CapitalG, CVS Health Ventures, Lightspeed Venture Partners, Redpoint, Spark Capital, NVentures, SV Angel.
Source · abridge.com ↗Series C
US$150 million
Abridge announced the round alongside an agreement with Yale New Haven Health to deploy its clinical documentation tools across the system.
Led by Lightspeed Venture Partners, Redpoint. Participation included IVP, Spark Capital, Union Square Ventures, Bessemer, Wittington Ventures, CVS Health Ventures.
Source · abridge.com ↗Series B
US$30 million
Abridge raised the round to bring its clinical documentation software to more US health systems, expanding adoption beyond its early deployments.
Led by Spark Capital. Participation included Bessemer, CVS Health Ventures, UC Investments.
Source · abridge.com ↗Series A-1
$12.5M
Abridge launched its enterprise documentation product alongside the round. It said the capital would grow its team and fund research into automating clinical documentation.
Led by Wittington Ventures. Participation included Union Square Ventures, Bessemer, Pillar Venture Capital, UPMC Enterprises, Yoshua Bengio, Whistler Capital.
Source · abridge.com ↗
Abridge Founding Team
Abridge’s founding team combined clinical practice, machine learning and speech research to tackle a problem familiar to clinicians: turning medical conversations into usable records.
- Shiv Rao was a practicing cardiologist and had worked at UPMC Enterprises before co-founding Abridge. He brought firsthand experience of clinical documentation.
- Sandeep Konam brought a background in robotics and machine learning and became Abridge’s CTO.
- Florian Metze brought research experience from Carnegie Mellon to the founding team.
Abridge Products
Abridge Company Development
UPMC’s Pilot Becomes a Health-System Rollout
UPMC was one of the first hospital systems to pilot Abridge. Its later decision to extend the platform across the enterprise marked the shift from testing ambient notes in a limited setting to deploying them as a shared clinical workflow.
Abridge Competitive Landscape
What Happens After the Clinical Note
Abridge and Ambience Healthcare capture clinician-patient conversations for documentation. Ambience also makes coding and billing part of its product scope, giving hospital buyers a reason to compare how much of the work after the note each deployment can cover.
FAQ
How do ambient clinical notes differ from a visit transcript?
A transcript records speech. A clinical note organizes the encounter into documentation used by care teams. Clinicians still need to review the output for accuracy and omissions.
Does funding establish that an AI scribe is clinically safe?
No. Financing does not substitute for clinical validation, privacy review or evaluation in a specific health system.
Why do health-system integrations matter for documentation software?
A useful note must fit existing review and electronic health record workflows. Deployment work can therefore matter alongside the underlying speech and language models.
Does Abridge’s Series E amount equal its lifetime funding?
The selected Series E is one financing event. Its amount must not be presented as the sum of all earlier rounds.
Why can an announcement omit a valuation that reporting supplies?
Companies can announce a financing without publishing every term. Read the linked source to distinguish company-disclosed terms from a valuation attributed to reporting.
What should clinicians assess beyond an ambient AI vendor’s investors?
Evaluate note quality, specialty coverage, consent processes, data handling and the burden of correcting errors in the actual clinical workflow.